Probing human cardiovascular congenital disease using transgenic mouse models.
about
Transforming growth factor Beta2 is required for valve remodeling during heart developmentMurine fetal echocardiography.Cardiac-specific inducible and conditional gene targeting in mice.Models in researching cardiovascular morphogenesis.Knock-in mice harboring a Ca(2+) desensitizing mutation in cardiac troponin C develop early onset dilated cardiomyopathy.High-speed, high-frequency ultrasound, in utero vector-flow imaging of mouse embryos.
P2860
Probing human cardiovascular congenital disease using transgenic mouse models.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Probing human cardiovascular congenital disease using transgenic mouse models.
@en
Probing human cardiovascular congenital disease using transgenic mouse models.
@nl
type
label
Probing human cardiovascular congenital disease using transgenic mouse models.
@en
Probing human cardiovascular congenital disease using transgenic mouse models.
@nl
prefLabel
Probing human cardiovascular congenital disease using transgenic mouse models.
@en
Probing human cardiovascular congenital disease using transgenic mouse models.
@nl
P2860
P1476
Probing human cardiovascular congenital disease using transgenic mouse models.
@en
P2093
Paige Snider
Simon J Conway
P2860
P304
P356
10.1016/B978-0-12-384878-9.00003-0
P577
2011-01-01T00:00:00Z